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TyrosinaseThe antiproliferative potential of chloroform,methanol and butanol extracts fromDaphne gnidium leaves on B16-
F0 and B16F-10 melanoma cells was assessed. Cell viability was determined using the MTT assay, and ﬂow cy-
tometry was used to analyse effects of extract on progression through the cell cycle and apoptosis. In addition,
amounts of melanin and tyrosinase activity were measured spectrophotometrically at 475 nm. Chloroform
extract exhibited signiﬁcant anti-proliferative activity after incubation with the two types of tumour skin cells.
Increase of tyrosinase activity, and of melanin synthesis which are markers of differentiation of malignant mela-
noma cells, were observedwith the chloroform extract. Furthermore, cell cycle analysis revealed that B16-F0 and
B16-F10 cells treated with chloroform extract were arrested predominantly in S phase.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Traditional herbs and plants are widely used for their medicinal
properties (Ivanova et al., 2005). The search for, and characterization
of, new pharmaceutical and healthcare products from natural sources
have increased over the last few years. Such products may provide
beneﬁts to humans as antioxidants, anti-inﬂammatory and antihyper-
tensive drugs (Roh et al., 2004). Plant-derived products are becoming
increasingly accepted and adopted by the cosmetic industry. Conse-
quently, research interest in the use of natural products, such as
chemical extracts from medicinal plants, herbs, and spices, for the
development of alternative food additives and cosmetic products is
considerable (Miyazawa and Tamura, 2007; Zhong et al., 2006).
The World Health Organization (WHO) has emphasized the impor-
tance of the traditional indigenous medicines, since a large majority of
rural people in the developing countries still use these medicines as
the ﬁrst defence in health care (Goleniowski et al., 2006). Globally,
about 85% of all medications for primary health care are derived from
plants (Farnsworth, 1988). Skin is the largest organ of the body. It serves
many important functions, including protection, percutaneous absorp-
tion, temperature regulation, ﬂuid maintenance, sensory and disease
control (Gebelein, 1997). Skin complaint affects all ages from the neo-
nate to the elderly and cause harm in number of ways. It has been216 73 461 150.
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y Elsevier B.V. All rights reserved.estimated that skin diseases amount are as high as 34% of all occupational
diseases (Spiewak, 2000). Traditional medicinal resources, especially
plants, have been found to play an important role in the management
of dermatological conditions (Saikia et al., 2006).
Daphne gnidium is an evergreen shrub that grows in the Mediterra-
nean area and can grow to a height of 2 m. Themethanol extract obtain-
ed from the leaves of D. gnidium is known to possess antibacterial and
antimycotic activities (Iauk et al., 1996, 1997) and a good cutaneous tol-
erability, whereas the bark extract induces photochemical skin damage
(Rapisarda et al., 1998). However, some compounds like daphnoretin
and apigenin existing in the leaves of this plant (Deina et al., 2003)
showed antitumour activity (Hall et al., 1982; Mak et al., 2006). That's
why we undertook in this present work the study of the effect of
chloroform, methanol and butanol extracts on proliferation and mela-
nogenesis of B16 melanoma cells. In fact, poor therapeutic results have
been reported for treatment of malignant melanoma; therefore, in this
studywe have investigated inhibitory capacity of chloroform,methanol
and butanol extracts from D. gnidium on proliferation of two types of
tumour skin cells; B16-F0 and B16-F10 mouse melanoma cell lines.
2. Material and methods
2.1. Preparation of extracts
The powdered leaves were macerated in methanol for 10 days with
continuous stirring, ﬁltered, and the solvent was evaporated. The ob-
tained extractwas dissolved in 100%water, and then several extractions
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ethyl acetate andbutanol.Methanol extractwas extractedusing a Soxhlet
apparatus (AM Glassware, Aberdeen, Scotland, United Kingdom).
These extracts, with different polarities, were concentrated to dry-
ness and the residues were kept at 4 °C.
2.2. Determination of total polyphenol and ﬂavonoid content
The polyphenol content of D. gnidium extracts was quantiﬁed by the
Folin–Ciocalteau reagent (Yuan et al., 2005; Kumar and Chattopadhyay,
2006). Aliquots of test samples (100 μl) were mixed with 2.0 ml of 2%
Na2CO3 and incubated at room temperature for 2 min. After the
addition of 100 μl 50% Folin–Ciocalteau phenol reagent, the reaction
tube was further incubated for 30 min at room temperature, and ﬁnally
absorbance was read at 720 nm. Gallic acid (0.2 mg/ml) was used as a
standard. Polyphenol content was expressed according to the following
formula:
%Polyphenols ¼ DOExtract  0:2ð Þ=DOGallic acid½ =Extract concentrationð Þ
 100:
A known volume of each extract was placed in a 10 ml volumetric
ﬂask to estimate ﬂavonoid content according to the modiﬁed method
of Zhishen et al. (1999). After addition of 75 μl of NaNO2 (5%), 150 μl
of freshly prepared AlCl3 (10%), and 500 μl of NaOH (1 N), the volume
was adjusted with distilled water until 2.5 ml. After 5 min incubation,
the total absorbance was measured at 510 nm. Quercetin (0.05 mg/ml)
was used as a standard. Flavonoid content was expressed according to
the following formula:
%Flavonoids ¼ DOExtract  0:05ð Þ=DOQuercitin
 
=Extract concentration
 
 100:
2.3. Cell lines and culture conditions
B16-F0 and B16-F10, mouse melanoma cell lines were cultured in
DMEM supplemented with 10% heat-inactivated Foetal Bobine
Serum (FBS), 1% Non Essential Amino acid (NEA) (100×), 1% vitamins
(100×), 1% penicillin (10,000 U/ml)–streptomycin (10,000 μg/ml)
and 1% sodium pyruvate 100 mM. Cells were grown at 37 °C in a hu-
midiﬁed atmosphere containing 5% CO2.
2.4. Viability test
The effects of chloroform, methanol and butanol extracts on the
viability of B16-F0 and B16-F10 cells were determined using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
TheMTT colorimetric assaywas performed in 96-well plates. B16-F0
and B16-F10 cells were seeded respectively, at concentration of
2500 cells/well and incubated for 24 h at 37 °C. After 24 h incuba-
tion, various concentrations ranging from 10 to 400 μg/ml (100 μl)
of extracts, were added to cultures and incubated for additional 24
and 48 h at 37 °C. Controls were performed with the same ﬁnal
DMSO concentrations (0.3%) inmedia as in samples. Then,MTT solution
(5 mg/ml in PBS, pH = 7.4) was added (10 μl/well) to cultures. After
4 h incubation at 37 °C, 100 μl of SDS 10%-HCl 1% (0.01 N) solution
was added to each well, and plates were incubated for an additional
3 h at 37 °C. Amounts of purple formazan formed were determined
by measuring absorbance at 540 nm (Moongkarndi et al., 2004).
Inhibition percentage (IP %) of cell viability was calculated according
to the following formula:
Inhibition percentage of cell viability %ð Þ
¼ 1− OD treated cells=OD control cellsð Þð Þ  100where ODof treated cells was optical density of cells treatedwith differ-
ent amounts of the tested extracts and OD of control cells was optical
density of cells treated with vehicle solution.
2.5. Cell cycle analysis using ﬂow cytometry
Mouse melanoma cells B16-F0 and B16-F10 (5 × 105 cells) were
seeded into a 50 cm2 culture dish and incubated for 24 h. Cells were
treated with different concentrations of extracts for 48 h, trypsinized
and washed twice in Phosphate Buffer Saline (PBS) (pH = 7.4). Cells
were harvested and 106 cells were resuspended in solution containing
30% cold PBS (pH = 7.4) and 70% cold ethanol. Then, they were stored
at 4 °C until analysis. On day of analysis, cells were incubated 15 min at
room temperature and washed twice in cold PBS (pH = 7.4). After
treatment with RNase A (10 μg/ml) for 30 min at room temperature
and staining with 50 μl propidium iodide (1 mg/ml) for 10 min, cell
cycle analysis was conducted using FACS system (BD Biosciences, San
Jose, CA, USA). Percentages of cells in each phase of the cell cycle were
calculated.
2.6. Determination of melanin content
Melanin release by cells was measured, as described previously
(Siegrist and Eberle, 1986). Brieﬂy, B16-F0 cells (5 × 105) were seeded
into a 50 cm2 culture dishwith 10 ml of culturemedium, and incubated
for 24 h. Then, cells were treated with chloroform extract (50, 100 and
200 μg/ml) for 48 h. After treatment,melanogenesis activity (closely re-
lated to the amount of produced melanin) was estimated from amount
of melanin secreted into cultured medium (extracellular melanin) and
melanin retained in cells (intracellular melanin). Adherent cells were
detached by incubation in trypsin (2.5%)/ethylenediamine tetraacetic
acid (0.11%); 5 × 105 cells were resuspended in 1 ml of Triton ×100
(0.1% in PBS). Spectrophotometric absorbance of extra- and intracellular
melanin content was measured at 475 nm. Absorbance was compared
against a standard curve of known concentration of synthetic melanin
and amounts estimated.
2.7. Tyrosinase activity
Tyrosinase enzyme activity was estimated by measuring rate of
L-3,4-dihydroxyphenylalanine (L-DOPA) oxidation, as described previ-
ously (Takahashi and Parsons, 1992) with slight modiﬁcation. Brieﬂy,
cells (5 × 105) were treated with chloroform leaf extract of D. gnidium
(100 μg/ml and 200 μg/ml) for 48 h, 106 cells were then resuspended
in phosphate buffer (0.1 M; pH 6.8) containing 0.1% Triton×100. Lysate
was clariﬁed by centrifugation at 17,500 g for 10 min at 4 °C; 400 μl of
supernatant was mixed with 400 μl of the substrate L-DOPA (0.15%),
and absorbance was measured spectrophotometrically at 475 nm,
every minute for 6 min.
3. Results
3.1. Cell viability assay
The relationship between concentration of extracts and cell viability
inhibiting effect on B16-F0 and B16-F10 cells was investigated by the
MTT assay. MTT is a yellow water-soluble tetrazolium salt. Metabol-
ically active cells are able to convert the dye to water-insoluble dark
blue formazan by reductive cleavage of the tetrazolium ring. B16-F0
and B16-F10 cells were treated with leaf extracts of D. gnidium at
concentrations ranging from 50 μg/ml to 400 μg/ml for 24 and 48 h
at 37 °C.
Then IC50 values were determined graphically and the inhibition
percentages were calculated. The tested extracts inhibited proliferation
of B16-F0 and B16-F10 cells in a dose-dependent manner. The chlo-
roform extract exhibited the highest anti-proliferative effect on both
82 F. Chaabane et al. / South African Journal of Botany 90 (2014) 80–86B16-F0 and B16-F10 cells when compared to other tested extracts with
inhibition percentage of 95.19% and 82.42% respectively after 48 h of
incubation with 400 μg/ml of the chloroform extract (Figs. 1, 2). The
IC50 values were 150 and 200 μg/ml respectively after 48 h of treatment.
Methanol and butanol extracts exhibited the weakest anti-proliferative
effect on B16-F0 cells with inhibition percentage of 60% and 55.72% (at
the same concentration of 400 μg/ml), and an IC50 value of 225 μg ⁄ ml
and 332.5 μg/ml respectively after 48 h of incubation. However, meth-
anol and butanol extracts showed no signiﬁcant antiproliferative effect
on B16-F10 cells (Table 1).
3.2. Cell cycle analysis
Cell cycle distribution in B16-F0 and B16-F10 cells was studied after
exposure to different concentrations of chloroform, methanol and
butanol leaf extracts of D. gnidium.
B16-F0 and B16-F10 cells were treated respectively, with 50, 100
and 200 μg/ml of chloroform extract and 100, 200 and 400 μg/ml of
methanol and butanol extracts and cell cycle distributionwas examined
after 48 h of treatment.
B16-F0 and B16-F10 cells treated with 50 μg/ml and 100 μg/ml of
chloroform extract were arrested in S phase. In fact, percentage of
B16-F0 cells arrested in S phase were 55.25% and 60.19%, respectively,
after treatment with 50 and 100 μg/ml of chloroform extract, versus
28.07% with untreated cells. Percentage of B16-F10 cells arrested in S
phase was only 41.47% and 49.82%, respectively, after treatment with
50 and 100 μg/ml, versus 29.67% with untreated cells. Whereas, cells
treated with 200 μg/ml of chloroform extract were arrested in G2-M
phase. Percentage of B16-F0 and B16-F10 cells treated with 200 μg/ml
of chloroform extract and arrested in G2–Mwere 17.75% and 35.3% re-
spectively, versus 7.28%with untreated B16-F0 and 9.32%with untreat-
ed B16-F10.
Treatment of B16-F0 with 400 μg/ml ofmethanol extract showed an
accumulation of cells in G2–M phase. The percentage of cells in phase
G2–Mwas 17.75% versus 7.28% with untreated cells.
In addition, treatment of B16-F0 cells with 400 μg/ml of butanol
extract showed an accumulation of cells in G2–M phase. G2–M phase
percentagewas 14.32%, versus 6.39% in untreated cells (Tables 2 and 3).Fig. 1. Anti-proliferative effect of chloroform, methanol and butanol extracts on B16-F0 melan
treated with DMSO and cells treated with the extract. (ANOVA followed by t student test.)3.3. Effect of chloroform extract on melanin synthesis and
tyrosinase activity
To investigate the effect of D. gnidium leaf extracts on melanin syn-
thesis, B16-F0melanoma cells were exposed to different concentrations
of plant extracts for 48 h, and thenmelanin contentsweremeasured. As
shown in (Fig. 3) the melanin synthesis was signiﬁcantly stimulated
after treatment with the chloroform extract in a dose-dependent man-
ner. Results indicate that chloroform extract signiﬁcantly stimulated
production of intra- and extracellularmelanin (48.77 μg/5 × 105 adher-
ent cells and 33.11 μg/ml of supernatant, at the dose of 200 μg/m)
when compared to untreated cells (12.88 μg/5 × 105 adherent cells
and 12 μg/ml of supernatant respectively), as well as tyrosinase activity
in B16-F0 cells, in a time-dependent manner (Fig. 4).
4. Discussion
Chloroform extract possessed an inhibitory effect on both B16-F0
and B16-F10 cell proliferation. However, methanol and butanol extracts
showed a signiﬁcant antiproliferative effect only on B16-F0 cells. This
result should be explained by the difference between the two cell
lines as far as they have different malignant potentials in vivo. The
B16-F0 cells have low metastatic potential and the B16-F10 cells have
high metastatic potential. Anti-proliferative activity of chloroform,
methanol and butanol extracts may be attributed to the presence of
speciﬁc components such as polyphenols and ﬂavonoids. In fact, the
chemical study of the tested extracts showed the presence of polyphe-
nols in chloroform, methanol and butanol extracts and ﬂavonoids in
methanol and butanol extracts (data not shown). The association
between ﬂavonoids and reducing cancer risk has been reported in
previous studies that showed a decrease in cancer risk with consumption
of vegetables and fruits rich with ﬂavonoids. In fact, studies involving
tangeretin, a ﬂavonoid present in citrus fruits, have pointed to a powerful
antiproliferative effect on different cell lines, including B16-F10 (Martinez
et al., 2001) and SK-Mel-1 melanoma (Yanez et al., 2002). Apigenin, a
common dietary ﬂavonoid inhibits the proliferation of A2780 human
ovarian cancer cell (Li et al., 2009). In addition, kaempferol-7-O-β-D-
glucoside, which belongs to ﬂavonoid glycoside, displayed markedoma cells *P b 0.05, **P b 0.01 and ***P b 0.001 mean signiﬁcant difference between cells
****
***
***
***
***
***
0
10
20
30
40
50
60
70
80
90
50µg/ml 100µg/ml 200µg/ml 400µg/ml
In
hi
bi
tio
n 
pe
rc
en
ta
ge
 o
f c
el
l v
ia
bi
lit
y 
(%
)
24H
48H
Fig. 2.Anti-proliferative effects of chloroform extract on B16F10melanoma cells. *P b 0.05 and ***P b 0.001mean signiﬁcant difference between cells treatedwith DMSO and cells treated
with the extract. (ANOVA followed by t student tests.)
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et al. (2003) showed the presence of ﬂavonoides (apigenin, luteolin,
quercetin etc.) in extracts from leaves of D. gnidium. Our chemical
study of methanol extract by HPLC showed the presence of apigenin-
7-glucoside and luteolin-7-glucoside in this extract (data not shown).
To identify whether the growth inhibitory effect of D. gnidium ex-
tracts was caused by speciﬁc perturbation of cell cycle-related events,
the DNA contents of both B16-F0 and B16-F10 cells were measured by
means of ﬂow cytometric analysis.
It appears that low concentrations of the extracts caused an increase
in the proportion of cells at the S phase of the cell cycle. Whereas, high
concentrations caused accumulation of cells at G2–M phase. Majewska
et al. (2006) reported that Rhodiola rosea extract reduces the proportion
of HL60 cells in G1 and G2/M phase. Whereas, it increases cells in S
phase. This was dependent on the period of incubation and concentra-
tion of the extract. In addition, the inhibition of proliferation of HL-60
cells by baicalein from a methanolic extract of Oroxylum indicum was
associated with the accumulation of cells at S or G2/M phases (Roy
et al., 2007).
Different mechanisms have been linked to ﬂavonoid mediated cyto-
toxicity, including induction of cell cycle arrest (Lepley et al., 1996). The
gallic and ferulic acids have been reported to cause G2–M arrest (Lee
et al., 2008). It was also demonstrated that a mixture of polyphenols
from an aqueous extract of cinnamon possessed anticancer properties
by blocking cell cycle progression of leukemic cell lines at the G2–M
phase (Schoene et al., 2005). On the other hand, melanoma cells have
low levels of spontaneous apoptosis and are relatively resistant to
drug-induced apoptosis (Soengas and Lowe, 2003), which is likely to
underlie drug-resistance in melanoma. Therefore, the ability of chloro-
form (12.28% of apoptotic cells at 200 μg/ml) and methanol (7.46% of
apoptotic cells at 400 μg/ml) extracts to induce apoptosis in B16-F0 tu-
mour cells makes these extracts a promising candidate for melanomaTable 1
IC50 values of Daphne gnidium leaf extracts on the proliferation of B16-F0 and B16-F10
melanoma cells.
Extracts Time of incubation (h) IC50 (μg/ml)
(B16F0)
IC50 (μg/ml)
(B16F10)
Chloroform extract 24 200 275
48 150 200
Methanol extract 24 225 –
48 275 –
Butanol extract 24 – –
48 332.5 –
–: The inhibition percentages obtained with this extract are less than 50%.treatment, either alone or in combination with other anti-melanoma
therapies. The apoptotic cells can be recognized by ﬂow cytometry
through their diminished stainability with the DNA-speciﬁc ﬂuoro-
chrome propidium iodide (PI), in which the hypodiploid population can
be quantiﬁed by DNA content frequency histograms (Bao et al., 2007).
In fact, Chaouki et al. (2009) demonstrated that treatment of MCF7
cells with ethyl acetate extract from D. gnidium roots increased the
apoptotic ratio to 1.6 and 2.6 at 500 and 1000 μg/ml of extract
respectively.
Thus, in the present study, we provide evidence that treatment with
chloroform extract is able to induce differentiation of B16-F0melanoma
cells reverting them fromproliferating to the differentiated state. In fact,
chloroform extract showed a melanogenesis stimulation activity in a
concentration-dependent manner in murine B16-F0 melanoma. In-
duction of melanogenesis is considered as a well-known marker of
differentiated melanoma cells (Edward et al., 1988). It is also report-
ed that the differentiated melanoma is associated with slower cell
proliferation (Puri et al., 2004). However, other plant extracts were
reported to inhibit melanogenesis. In fact, the methanolic extract
from the whole plants of Anastatica hierochuntica, an Egyptian plant,
was found to inhibit melanogenesis in murine B16 melanoma 4A5
cells (Nakashima et al., 2010). In addition, the methanol extract of
Cinnamomum cassia Presl showed the suppression of melanin synthesis
(Nguyen et al., 2007).
The rate-determining step of melanin synthesis involves tyrosinase.
Tyrosinase has a role in the oxidation of L-tyrosine to L-3-(3,4-
dihydroxyphenyl)-alanine (L-DOPA) and of DOPA to dopaquinone,
which is the initial step in melanin synthesis (Lin et al., 2007).
The study of Ye et al. (2010) suggested that apigenin and icariin
exert potent melanogenic activities through, at least in part, upregulat-
ing the protein expression levels of melanogenic enzymes in B16 cells.
Whereas, Hirata et al. (2007), reported increasing of melanogenesis in
B16 cells incubated with cubebin through the enhancement of tyrosi-
nase expression mediated by activation of p38 MAPK. On the other
hand, Cha et al. (2012) have demonstrated that the inhibitory effect of
Phellinus linteus on melanogenesis was associated with a decrease in
tyrosinase activity. Skandrani et al. (2010) have also demonstrated
that chloroform extract fromMoricandia arvensis enhances melanogen-
esis and tyrosinase activity. Chaabane et al. (2012) have shown that
stimulation of melanogenesis in B16-F0 cells, incubated with ethyl
acetate extract from D. gnidium leaves was associated with enhancing
of the tyrosinase activity. This result is in accordance with results
found in this study. It can be concluded from the two studies that differ-
ent natural combinations (in a qualitative or quantitative manner) of
compounds existing in D. gnidium leaf extracts have different effects
Table 3
Cell cycle distribution of B16F-10 cells after treatment with Daphne gnidium leaf extracts.
Doses (μg/ml) G0–G1
(%)
G2–M
(%)
S
(%)
Apoptosis (%)
Control 64.65 ± 3.5 9.32 ± 3.1 29.67 ± 1.5 0.04 ± 0.01
Chloroform extract 50 46.26 ± 3.5 12.27 ± 2.5 41.47 ± 1.5*** 0.8 ± 0.01***
100 38.88 ± 3.4 11.3 ± 0.91 49.82 ± 3.6*** 1.12 ± 0.07***
200 31.87 ± 3.6 35.3 ± 3.5*** 32.83 ± 3.5 1.83 ± 0.91*
Methanol extract 100 52.1 ± 0.94 10.01 ± 3.4 37.89 ± 2.5 0.43 ± 0.001***
200 52.33 ± 2.5 9.35 ± 1.5 38.32 ± 1.5 1.62 ± 0.7*
400 52.19 ± 0.91 13.07 ± 0.028 34.74 ± 2.3 0.91 ± 0.2*
Butanol extract 100 54.62 ± 0.94 11.96 ± 0.7 33.42 ± 3.4 0
200 58.6 ± 0.96 11.53 ± 0.38 29.87 ± 3.5 0.06 ± 0.001
400 60.29 ± 1.5 13.35 ± 1.34 26.36 ± 2.5 0.35 ± 0.07**
Values represent the mean ± SD of three separate experiments. The statistical signiﬁcance of results was evaluated by the Student's t-test. *P b 0.05, **P b 0.01 and ***P b 0.001 mean
signiﬁcant difference between control and treated samples.
Table 2
Cell cycle distribution of B16-F0 cells after treatment with Daphne gnidium leaf extracts.
Doses
(μg/ml)
G0–G1
(%)
G2–M
(%)
S
(%)
Apoptosis
(%)
Control 60.97 ± 3.5 7.28 ± 1.5 28.07 ± 2.3 0.18 ± 0.01
Chloroform extract 50 42.03 ± 3.5 2.71 ± 0.01 55.25 ± 4.5*** 0.32 ± 0.01***
100 38.22 ± 3.2 1.59 ± 0.01 60.19 ± 3.4*** 1.57 ± 0.01***
200 42.38 ± 2.2 17.75 ± 3.5** 39.86 ± 3.5 12.28 ± 2.1***
Methanol extract 100 65.45 ± 1.75 8.04 ± 1 26.51 ± 3.2 0.25 ± 0.07
200 62.56 ± 2.3 8.77 ± 1.1 28.67 ± 3.4 0.04 ± 0.01
400 56.32 ± 2.5 17.75 ± 3.5** 25.93 ± 2.5 7.46 ± 1.4***
Butanol extract 100 70.23 ± 3.4 6.54 ± 1 23.24 ± 2.5 0.24 ± 0.01
200 67.94 ± 2.9 6.29 ± 1.5 25.77 ± 0.09 0.45 ± 0.001
400 65.34 ± 3.4 14.32 ± 3.4 20.34 ± 0.01 1.31 ± 0.01***
Values represent the mean ± SD of three separate experiments. The statistical signiﬁcance of results was evaluated by the Student's t-test. *P b 0.05, **P b 0.01 and ***P b 0.001 mean
signiﬁcant difference between control and treated samples.
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both ethyl acetate and chloroform extracts that the combination be-
tween beta amyrin acetate and dihydrosesamin enhances melano-
genesis and antiproliferative activity. However, only chloroform extract
induces apoptotic death pathway. This should be ascribed to other com-
pounds present in a less important manner than the major ones above
cited, or that the proportion of each compound is different from an
extract to another. The combination between daphnetin and apigenin-
7-glycoside in TOF extract and between daphnetin and luteolin-7-
glycoside in the aqueous extract revealed an antiproliferative effect
against B16 cell lines.Whereas, when the three compounds (daphnetin,
luteolin-7-glycoside and apigenin-7-glycoside) coexist (in methanolFig. 3. Effect of chloroform extract on melanin content in B16-F0 cells after 48 h incubation. *P
cells treated with the extract. (ANOVA followed by t student tests.) A: Intracellular melanin coextract), or when only daphnetin is detected (in butanol extract) the
antiproliferative activity disappeared (Chaabane et al., 2012). These
studies on different extracts from D. gnidium may present a way to
detect the extract presenting the most important effect on melano-
genesis and apoptosis, so that we have not to purify the compounds,
and thus cost treatments should be less expensive.
5. Conclusion
In this study we reported that chloroform extract inhibited popula-
tion growth of mouse melanoma B16-F0 and B16-F10 cells in a dose-
dependent manner by inducing cell cycle arrest.b 0.05 and ***P b 0.001 mean signiﬁcant difference between cells treated with DMSO and
ntent. B: Extracellular melanin content.
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Fig. 4. Effect of chloroform extract (100 and 200 μg/ml) on tyrosinase activity in B16-F0 cells after 48 h of incubation.
85F. Chaabane et al. / South African Journal of Botany 90 (2014) 80–86Moreover, exposure of B16-F0 cells to chloroform extract stimulated
expression ofmarkers ofmelanoma cell differentiation such as tyrosinase
activity and enhanced production of melanin, indicating that the tested
extract triggered the cell differentiation programme.
However, further studies are required for better understanding of
mechanism of action, including the downstream transcription factors
and the melanin biosynthetic pathway.Acknowledgements
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